Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q _________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 500 3rd St. OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Suite 510 For the transition period from to ...

Exhibit 99.1 Doximity Announces Fiscal 2025 Third Quarter Financial Results Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year SAN FRANCISCO, Calif., February 6, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 uniqu ...

For Immediate ReleasesChicago, IL – January 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include, Doximity (DOCS) , Omnicell (OMCL) , Embecta Corp. (EMBC) , Cencora, Inc. (COR) and the Global Telemedicine & Digital Health ETF (EDOC) .Here are highlights from Thursday’s Analyst Blog:4 MedTech Stocks Poised to Thrive ...

Investment Analysis - The analyst recommended a hold rating for Doximity (NYSE: DOCS) on 2nd October last year, as the valuation was believed to have already priced in near-term upside [1] - An ideal investment is considered to be one that operates in a sector projected to experience structural (organic) growth exceeding GDP growth over the next 5-10 years [1] - The investment should also profit from sustainable competitive advantages that translate into attractive unit economics [1] - The company should be managed by competent, ethical, and long-term thinkers [1] - The valuation of the investment should be fair [1]

Doximity (DOCS) ended the recent trading session at $58.18, demonstrating a +0.61% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.16%, and the tech-heavy Nasdaq gained 0.98%.Prior to today's trading, shares of the medical social networking site had gained 19.98% over the past month. This has outpaced the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34% in that time.The investment community will ...

The healthcare sector experienced a dynamic year, shaped by factors such as rising patient volumes, higher occupancy rates, escalating medical costs, inflationary pressures and the resumption of elective procedures, particularly among seniors. Key trends, including the increasing use of artificial intelligence (AI), an aging population, a rise in chronic diseases and advancements in personalized medicine, are expected to persist into 2025, driving further transformation.The sector is undergoing significant ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Doximity (DOCS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Doximity is a member of the Medical sector. This group includes 1022 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks S ...

The broader U.S. equity markets have witnessed significant volatility over the past few trading days as the post-election rally fizzled due to concerns regarding potential policy shifts under the new administration. The markets were further weighed down by apprehensions about the pace of interest rate cuts as healthy economic growth offered some leeway to go slow on the proposed monetary easing. However, solid earnings from blue-chip technology stocks helped markets recover some lost ground. With NVIDIA res ...

Doximity (DOCS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The upward trend in estimate revisions for this medical social networking site reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings est ...

Doximity calls themselves the digital platform for doctors. They offer an integrated suite of tools that enables marketing, staffing, and workflow management tools including telehealth, scheduling, and document management. More than 90% ofMichael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. H ...